Return On Equity	(Dec 31 2022) 2022	(Dec 31 2021) 2021	(Dec 31 2020) 2020	(Dec 31 2019) 2019	(Dec 31 2018) 2018
Y / Y Equity Change	32.36 %	-5.14 %	3.82 %	11.45 %	-10.26 %
Y / Y Net Income Change	-	-	-16.24 %	-55.14 %	-38.58 %
Return On Equity	15.26 %	-	6.45 %	7.99 %	19.84 %

EGRX all Ratios >> Back to EGRX Management Effectiveness >> See Quarterly EGRX Return On Equity

You need to upgrade your Flash Player

Roe Comment

In (Dec 31 2022) ROE improved to 15.26 % compare to previous year, due to net income growth.

Financial Statements
Eagle Pharmaceuticals Inc 's Equity	$ 234 Millions	Annual EGRX's Balance sheet
Eagle Pharmaceuticals Inc 's Annual Income	$ 36 Millions	Annual EGRX's Income Statement
Where are EGRX's Income coming from?		Visit EGRX's Income by Segment

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.